血浆线粒体DNA与系统性硬化症相关间质性肺病疾病进展相关
本研究探讨系统性硬化症相关间质性肺病(SSc-ILD)中血浆线粒体DNA(mtDNA)与疾病进展及固有免疫DNA感应受体的关联。在两个独立SSc-ILD队列中,血浆mtDNA浓度升高且反映通气功能下降,并与TLR-9和cGAS/STING激活及I型干扰素、IL-6表达正相关。mtDNA由细胞外囊泡携带,未氧化,提示其作为内源性配体参与SSc-ILD的固有免疫激活。
要点
- SSc-ILD患者血浆mtDNA浓度升高,且反映通气功能下降。
- 血浆mtDNA与TLR-9和cGAS/STING激活及I型干扰素、IL-6表达正相关。
- mtDNA由细胞外囊泡携带,未氧化,提示多细胞来源。
核心结论
- SSc-ILD中细胞外囊泡包裹的mtDNA与临床结局及细胞内DNA感应受体激活存在先前未认识到的关联。
研究设计与样本
- 研究纳入正常供体和SSc-ILD外植体的人肺成纤维细胞,用合成CpG DNA处理并检测α-SMA表达和细胞外mtDNA。
- 在两个独立SSc-ILD队列及人口学匹配对照中评估血浆MT-ATP6浓度。
- 用HEK 293报告细胞评估血浆诱导TLR-9和cGAS/STING激活的能力。
- 检测血浆I型干扰素、IL-6和氧化DNA浓度,并对血浆沉淀的细胞外囊泡进行MT-ATP6浓度和蛋白质组学分析。
主要发现
- 正常肺成纤维细胞和SSc-ILD成纤维细胞在CpG刺激后α-SMA表达和MT-ATP6释放增加。
- 两个SSc-ILD队列血浆mtDNA浓度升高,反映通气功能下降,并与TLR-9和cGAS/STING激活及I型干扰素和IL-6表达正相关。
- 血浆mtDNA未氧化,由细胞外囊泡携带,其蛋白质组学特征提示多细胞来源。
临床怎么用
- 血浆mtDNA浓度可能作为SSc-ILD疾病进展和固有免疫激活的生物标志物,但需进一步验证。
局限性
- 原文未明确报告研究局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Systemic sclerosis-associated interstitial lung disease (SSc-ILD) is characterized by variable clinical outcomes, activation of innate immune pattern-recognition receptors (PRRs), and accumulation of α-smooth muscle actin (α-SMA)-expressing myofibroblasts. The aim of this study was to identify an association between these entities and mitochondrial DNA (mtDNA), an endogenous ligand for the intracellular DNA-sensing PRRs Toll-like receptor 9 (TLR-9) and cyclic GMP-AMP synthase/stimulator of interferon genes (cGAS/STING), which has yet to be determined. METHODS: Human lung fibroblasts (HLFs) from normal donors and SSc-ILD explants were treated with synthetic CpG DNA and assayed for α-SMA expression and extracellular mtDNA using quantitative polymerase chain reaction for the human MT-ATP6 gene. Plasma MT-ATP6 concentrations were evaluated in 2 independent SSc-ILD cohorts and demographically matched controls. The ability of SSc-ILD and control plasma to induce TLR-9 and cGAS/STING activation was evaluated with commercially available HEK 293 reporter cells. Plasma concentrations of type I interferons (IFNs), interleukin-6 (IL-6), and oxidized DNA were measured using electrochemiluminescence and enzyme-linked immunosorbent assay-based methods. Extracellular vesicles (EVs) precipitated from plasma were evaluated for MT-ATP6 concentrations and proteomics via liquid chromatography mass spectrometry. RESULTS: Normal HLFs and SSc-ILD fibroblasts developed increased α-SMA expression and MT-ATP6 release following CpG stimulation. Plasma mtDNA concentrations were increased in the 2 SSc-ILD cohorts, reflective of ventilatory decline, and were positively associated with both TLR-9 and cGAS/STING activation as well as type I IFN and IL-6 expression. Plasma mtDNA was not oxidized and was conveyed by EVs displaying a proteomics profile consistent with a multicellular origin. CONCLUSION: These findings demonstrate a previously unrecognized connection between EV-encapsulated mtDNA, clinical outcomes, and intracellular DNA-sensing PRR activation in SSc-ILD. Further study of these interactions could catalyze novel mechanistic and therapeutic insights into SSc-ILD and related disorders.
引用
- Ryu C, Walia A, Ortiz V, et al. Bioactive Plasma Mitochondrial DNA Is Associated With Disease Progression in Scleroderma-Associated Interstitial Lung Disease. Arthritis Rheumatol. 2020. PMID: 32602227. doi:10.1002/art.41418
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。